Quantcast
Tomato-Rich Diets May Help Reduce The Risk Of Developing

Tomato-Rich Diets May Help Reduce The Risk Of Developing Prostate Cancer

Chuck Bednar for redOrbit.com - Your Universe Online Men looking to reduce their risk of developing prostate cancer could benefit by consuming at least 10 servings of tomatoes per week, according to new research appearing in a recent edition of...

Latest Prostate cancer Stories

2014-09-02 08:26:41

Prostate Cancer Survivor Rodgers Invites Support for the Manogram® Project to Bring Life-saving Detection to Men BOSTON, Sept. 2, 2014 /PRNewswire-USNewswire/ -- With the White House announcing September as National Prostate Cancer Awareness Month, AdMeTech Foundation released a new awareness campaign featuring Boston Marathon legend and prostate cancer survivor Bill Rodgers. The public service announcement will run on WBZ-TV, the local Boston CBS affiliate throughout the month of...

2014-09-01 16:21:50

LONDON, Sept. 1, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Circulating Tumor Cell (CTC) Diagnostics: Technologies and Global Marketshttps://www.reportbuyer.com/product/2009162/Circulating-Tumor-Cell-CTC-Diagnostics-Technologies-and-Global-Markets.html STUDY GOALS AND OBJECTIVESThis report, PHM153A - Circulating Tumor Cell (CTC) Diagnostic: Technologies and Global Markets, gives market insight on monitoring tests used for cancer prognoses. The...

2014-08-28 12:29:07

Free Educational Session for prostate cancer patients, their spouses and advocates. DETROIT, Aug. 28, 2014 /PRNewswire-USNewswire/ -- The Barbara Ann Karmanos Cancer Institute, in collaboration with Wayne State University School of Medicine (WSU SOM), will present the fourth annual Prostate Cancer Symposium, Latest Treatment Advancements: What you learn here could save your life, Saturday, Sept. 20, from 8 a.m. - 2:30 p.m., at the Charles H. Wright Museum of African American History...

2014-08-28 12:27:19

Former NFL Star Chris Draft Honored for Passion and Commitment WASHINGTON, Aug. 28, 2014 /PRNewswire-USNewswire/ -- LUNGevity Foundation announces former NFL linebacker Chris Draft as the August LUNGevity Hero for his active effort in raising awareness of lung cancer and campaigning for critical funds for research. After his wife's battle with the disease and her passing just one month after their wedding, Draft has become an influential figure in the lung cancer community. In 2010, Draft's...

2014-08-27 23:08:41

Catalent, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that it is collaborating with privately held Australian biomarker research company, Minomic International Limited, to develop MIL-38, an antibody drug conjugate (ADC) for prostate cancer therapy. Under the agreement, Catalent will initially produce the antibody for a clinical study with a view to larger scale production subject...

2014-08-27 23:03:08

Fast paced sales growth sets a new company record and underscores the continued worldwide acceleration in demand for SonaCare’s unique HIFU platform technology. Charlotte, NC (PRWEB) August 27, 2014 NC. SonaCare Medical, LLC, the global leader in high intensity focused ultrasound (HIFU), announced record-setting sales of 15 HIFU devices over the past twelve months pointing to a steady worldwide surge in demand for the company’s ablation technology. “It is truly exciting to see the...

2014-08-21 23:16:22

Gallus BioPharmaceuticals, LLC, a premier, full service biopharmaceutical contract development and manufacturing organization announced today that it has been selected by Progenics Pharmaceuticals, Inc., an oncology company focused on the development of innovative approaches to targeting and treating cancer, to manufacture the anti-prostate specific membrane antigen (PSMA) monoclonal antibody used in Progenics’ PSMA ADC product candidate. St. Louis, MO (PRWEB) August 21, 2014 Gallus...

2014-08-21 16:24:50

ENSPIRIT Trial to Continue as Planned Following Completion of the First of Two Interim Futility Analyses BOTHELL, Wash. and VANCOUVER, British Columbia, Aug. 21, 2014 /PRNewswire/ -- OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) announced today that the Phase 3 ENSPIRIT trial, evaluating custirsen in the treatment of non-small cell lung cancer (NSCLC), is continuing as planned per the recommendation of the Independent Data Monitoring Committee (IDMC) based upon completion of the...

2014-08-21 12:29:55

WASHINGTON, Aug. 21, 2014 /PRNewswire-USNewswire/ -- ZERO - The End of Prostate Cancer is hosting 16 run/walk events across the nation during September, Prostate Cancer Awareness Month, to raise funds and awareness to end prostate cancer, a disease that affects one in seven American men. http://photos.prnewswire.com/prnvar/20130129/DC50244LOGO "Thousands are making a choice for a healthy lifestyle and celebrating Prostate Cancer Awareness Month by walking or running," ZERO CEO Jamie...

2014-08-19 16:29:08

Funding To Increase Manufacturing Capacity for Ramp-Up of Programs BETHESDA, Md., Aug. 19, 2014 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, announced today that the $17.5 million convertible note offering announced last Thursday, August 14, 2014, has closed. The three-year notes have a 5% interest rate and are convertible at $7.30 per share of common stock. The...


Word of the Day
monteith
  • A large punch-bowl of the eighteenth century, usually of silver and with a movable rim, and decorated with flutings and a scalloped edge. It was also used for cooling and carrying wine-glasses.
  • A kind of cotton handkerchief having white spots on a colored ground, the spots being produced by a chemical which discharges the color.
This word is possibly named after Monteith (Monteigh), 'an eccentric 17th-century Scotsman who wore a cloak scalloped at the hem.'
Related